Introduction
The members of the NF-kB transcription factor family are essential modules of signal transduction cascades in innate and adaptive immune reactions and inflammatory or stress responses (Hatada et al., 2000) . Their activation is further required for embryonic development of epidermal and secondary lymphoid organs, for osteoclast differentiation and hematopoiesis (Li and Verma, 2002) . In the activation process, NF-kB is liberated from cytoplasmic IkB proteins by induced IkB degradation. IkBs are phosphorylated by an IkB kinase (IKK) complex, which invokes subsequent IkB polyubiquitination by the SCF bTrCP complex and degradation by the 26S proteasome (Ghosh and Karin, 2002) .
The IKK complex is composed of two related kinase molecules, IKKa and IKKb (also called IKK1 and IKK2) and a regulatory molecule, IKKg (also called NEMO). While genetic data suggest that IKKb is the essential kinase subunit to phosphorylate IkB molecules in response to proinflammatory signals (Ghosh and Karin, 2002) , selective functions ascribed to IKKa are to transmit morphogenic signals. IKKa is essential for RANK activated cyclin D1 expression and mammary epithelial cell proliferation and for epidermal keratinocyte differentiation Hu et al., 2001) . Furthermore, IKKa is specifically required for a novel NF-kB activation pathway, which is activated by the LTb receptor and is thought to involve phosphorylation of the NF-kB precursor protein p100 by IKKa (Senftleben et al., 2001; Dejardin et al., 2002; Mordmuller et al., 2003; Yilmaz et al., 2003) . IKKg is essential for activation of the kinase complex by proinflammatory stimuli and sequesters IKKa and IKKb homo or heterodimers through an N-terminal domain, which binds to a short C-terminal segment present in each kinase (May et al., 2000) . IKKg forms a tetrameric scaffold that can assemble two kinase dimers to facilitate trans-autophosphoryation and its tetrameric state was found to be requisite to kinase activation (Tegethoff et al., 2003) .
The exact ways by which IKK is activated, phosphorylation by upstream kinases or allosteric mechanisms depending on interaction, are not well understood. For the TNFa pathway, it has been shown that the IKK complex can be recruited along with TRAF2 and RIP1 into the ligand activated TNF receptor 1 proximal complex Zhang et al., 2000) . RIP1 binds to IKKg (Zhang et al., 2000) and is required for TNFa to induce IKK activity (Kelliher et al., 1998; Devin et al., 2000) Activation of IKK following recruitment could be due to an induced proximity mechanism, since RIP1 kinase activity is dispensable . In fact, enforced oligomerization of the IKKa or IKKb kinase domains or of the kinase binding region of IKKg can induce IKK and NF-kB (Poyet et al., 2000) .
The folding and regulation of the conformational state of a number of signaling molecules, including kinases and nuclear steroid hormone receptors, depends on heat shock protein Hsp90 family members and their co-chaperones (Stebbins et al., 1997; Maloney and Workman, 2002) . A requirement of Hsp90 for activation of NF-kB has been suggested by several studies that utilized the benzoquinone ansamycin compound geldanamycin (GA), an efficient and specific Hsp90 inhibitor (Whitesell et al., 1994) . GA inhibits LPS-or taxolinduced NF-kB activity, TNFa production in macrophages (Byrd et al., 1999; Chakravortty et al., 2001 ) and mitogen-induced NF-kB activity in spleen cells (Sugita et al., 1999) . The inhibitory effect of GA on TNFa mediated NF-kB activation could be caused by destabilizing effects on RIP1, an essential component assembled with activated TNF-R1 (Lewis et al., 2000) . Hsp90 and Cdc37 have been found to associate stoichiometrically with the IKK complex by binding to the IKKa and IKKb kinase domains. Disruption of this association by GA abolishes TNFa induced recruitment of the IKK complex to TNF-receptor 1 and activation of kinase activity (Chen et al., 2002) . Thus, in the TNFa pathway, Hsp90 is involved at multiple levels.
We have compared the requirement of Hsp90 for the activation of IKK and NF-kB by TNFa, IL-1b and PMA, stimuli that use distinct pathway components. We found that Hsp90 function is required in each case for IKK activation, which can be inhibited by short-time incubation with GA. Likewise, constitutive IKK activation in Hodgkin's lymphoma cells requires Hsp90 activity. Hsp90 is crucial for IKKa and b biogenesis, and inhibition for extended time results in IKKa and b depletion, involving the ubiquitin-proteasome pathway.
Results

Hsp90 function is required for constitutive IKK/NF-kB activity in lymphoma cells
The constitutive activation of NF-kB in Hodgkin/ReedSternberg (HRS) cells is caused by persistent activity of the IKK complex or by loss of functional alleles of the IkBa gene Krappmann et al., 1999) . To test the role of Hsp90, HRS cells were treated with GA, a selective Hsp90 inhibitor (Whitesell et al., 1994; Stebbins et al., 1997) (Figure 1 ). Constitutive NFkB activity was almost completely blocked by GA in HRS cell lines containing functional IkBa genes (L1236, HDLM-2, L540, Figure 1a , lanes 3-6, 9 and 10), while no overt effect was seen in cells devoid of wild-type IkBa (KM-H2, L428, lanes 1, 2, 7 and 8). GA inhibited constitutive NF-kB specifically, as it did not affect Oct1 DNA binding activity and, with the exception of L1236 cells, the constitutive AP-1 activity in HRS cells (Mathas et al., 2002) was not consistently altered.
The striking effect of GA on NF-kB activation only in HRS cells with wild-type IkBa indicates that constitutive IKK activity was inhibited and that the lack of wild-type IkBa in KM-H2 and L428 fully accounts for constitutive nuclear NF-kB activity in these cells, irrespective of IKK activation. In vitro kinase assays indeed revealed almost complete inactivation of IKK by GA in all HRS cell lines, independent of the IkBa status (Figure 1b) . However, loss of IKK activity could in part be attributed to decreased amounts of IKKa precipitated from GA treated cells (Figure 1b) . In HRS cells, GA in fact caused a decline of the expression levels of IKKa, IKKb, IKKg and of RIP1 to various extent, but not of p65 (data not shown).
These data thus suggest that GA mediated Hsp90 inhibition inactivates the IKK complex, and lowers NF-kB and IKK activation by proinflammatory and mitogenic stimuli is sensitive to Hsp90 inhibition It has previously been proposed that RIP1 destabilization accounts for the inhibition of the TNF-R1 pathway by GA, while as an alternative mechanism, impaired recruitment of the IKK complex to TNF-R1 was proposed (Lewis et al., 2000; Chen et al., 2002) . Since these reports only investigated the TNFa pathway and the inhibitory action of GA on constitutive NF-kB activation in HRS cells suggested a more general mechanism, we compared the effect of Hsp90 inhibition on transient NF-kB activation by TNFa, IL-1b and phorbolester (PMA). In fact, pretreatment with GA not only blocked activation of NF-kB DNA binding activity by TNFa but also inhibited activation by PMA or IL-1b in HeLa cells (Figure 2a) . Similar results were obtained in Namalwa B cells (data not shown).
A time course analysis of the inhibition of TNFa or PMA stimulated IKK activity by GA in Namalwa cells showed that the onset of decline of IKK kinase activity appeared to occur earlier than loss of IKK components or of RIP1 (Figure 2b ). A pretreatment with GA for 4 h already affected kinase activity with no pronounced loss of precipitated IKKa. However, partial depletion of RIP1 and IKKb likely contribute to diminished kinase activity at 4 h for TNFa and PMA, respectively. A reduction of IKK activity to basal level occurred after 14 h of GA pretreatment and was accompanied by a significant depletion of IKKa, IKKb and of RIP1 ( Figure 2b ). In HeLa cells the first drop in TNFainduced kinase activity was again observed at 4 h, while the depletion of IKKs and RIP1 was less and more delayed compared to Namalwa cells. In contrast to IKK, GA treatment seemed to modestly increase JNK1 protein levels, but not PMA-induced JNK kinase activity ( Figure 2c ). To further verify the specificity of the effects caused by the ansamycin antibiotic GA, we used radicicol (RC), a macrocyclic antifungal antibiotic as a structurally unrelated compound. Both, RC and GA bind to the ATP binding domain and inhibit the ATPase activity of Hsp90 (Maloney and Workman, 2002) . RC inhibited TNFa-induced IKK activity after short pretreatment and decreased IKK protein level after longer incubation in the same way as GA.
( Figure 2d and data not shown). Shorter incubation times were tested for IL-1b and revealed that IKK activation was severely impaired within 60 or 240 min of GA or RC pretreatment, respectively ( Figure 3a ). Likewise, constitutive IKK activity in HRS cells was reduced after short-time exposure to GA ( Figure 3b ). Thus, Hsp90 function is required not only for constitutive NFkB activation in HRS cells, but also for inducible IKK activation and, apparently in an independent mode, for maintaining steady-state levels of IKKs. The GA induced decay of RIP1 should not account for impaired IKK activation by IL-1b or PMA, since RIP1 is specifically required for the TNFa pathway (Hsu et al., 1996; Kelliher et al., 1998) .
A potential effect of GA on the Hsp90-IKK interaction was investigated by immunoprecipitations with an IKKg antibody (Figure 4 ). Binding of Hsp90 to the IKK complex was disrupted when cells were treated with GA for 8 or 14 h, while the total Hsp90 and IKKg protein levels in the input material were not affected during the same time course. Again, IKKa and IKKb amounts in the input material decreased at the latest time points. The fact that Hsp90 association with IKK was not affected at 4 h, when kinase activity had already declined, hints to a requirement of Hsp90 function for kinase activity, while bound to IKK.
The dual functional requirement of Hsp90 for IKK stabilization and activation as well as the physical interaction demonstrated for the endogenous proteins could be recapitulated with overexpressed IKKs. Similar to the endogenous components, overexpressed IKKb was depleted upon extended GA exposure, while levels of transfected IKKg were only marginally affected (Figure 5a ). Furthermore, both IKKa and IKKb coprecipitated with endogenous Hsp90 (Figure 5b ) The kinase sensitivity to Hsp90 inhibition was tested with overexpressed IKKb in the presence or absence of cotransfected IKKg. Enzymatic activity was in each case greatly diminished when cells were treated for 4 h with GA ( Figure 5c ). Of note, this incubation time did not affect expression levels of tagged IKKb (Figure 5a and c). Interestingly, GA did not only impair phosphorylation of the substrate IkBa, but also (trans)autophosphorylation of IKKb and IKKg. Thus, full activity of a transfected IKK complex depends on the function of endogenous Hsp90.
Following Hsp90 inhibition, newly synthesized IKKa and IKKb are polyubiquitinated and degraded by the proteasome Several other Hsp90 client proteins have been shown to be degraded by the proteasome following GA-treatment (Maloney and Workman, 2002) . For this reason, proteasomal degradation could also be responsible for However, it cannot be excluded that CHX treatment depletes an unknown unstable component specifically required for IKK polyubiquitination.
Therefore, the role of Hsp90 for IKKa and IKKb biogenesis and stability was analysed by pulse-chase analysis (Figure 7a ). In the absence of GA, radiolabeled FlagIKKb-transfected COS7 cells were treated with GA for 6.5 h or left untreated. ALLN was added for the last hour. Cycloheximide was added 30 min before the addition of ALLN, as indicated. FlagIKKb was immunoprecipitated from whole-cell extracts. Polyubiquitination was detected with a monoclonal antibody directed against ubiquitin and precipitated flagIKKb was controlled by Western blotting (IP WB). Polyubiquitinated species and molecular weight markers in kDa are indicated. Right panel: GA does not detectably induce polyubiquitination of tagged IKKg. Ubiquitin-modification of flagIKKg was analysed as described above for flagIKKb (c) GA-induces cycloheximide-sensitive polyubiquitination of cellular IKKa. The experiment was performed in Namalwa cells as described in (b) and IKKa was precipitated from whole-cell extracts. Specificity of immunoprecipitation was confirmed with an IgG2b isotype antibody (ctrl. Ig, lane 6) IKKa had an half-life of more than 1 h. This value was not decreased, when GA was added during the chase, but after completion of pulse-labeling (lanes 7-9 compared to 1-3). However, no radiolabeled IKKa was detectable when GA was present before and during pulse-labeling (lane 4-6). Similarly, IKKb amounts were strongly diminished by GA only when added during translation but not in the chase phase (lanes 4-6 compared to 7-9). The biosynthesis or stability of p65 was not influenced by Hsp90 inhibition in this experiment, ruling out a general effect of GA on translation. Pulse-chase analysis of overexpressed IKKa and IKKg also showed an impaired biosynthesis of flagIKKa and dramatic instability of the synthesized proteins when Hsp90 function was inhibited during the synthesis step ( Figure 7b , lanes 4-6 compared to 1-3). The biosynthesis and stability of flagIKKg was affected to a lesser 
Discussion
In this study we have investigated the requirement of Hsp90 family members for inducible and constitutive activity of the IKK complex by use of GA. This drug specifically inhibits the ATPase activity of Hsp90, which results in the degradation of many Hsp90 client proteins by the ubiquitin-proteasome machinery (Hohfeld et al., 2001; Young et al., 2001) . Many of these targets of Hsp90 are proteins involved in signal transduction processes and comprise transcription factors, including steroid hormone receptors and a number of tyrosine or serine/threonine kinases. As such, a growing list of kinases that regulate cellular proliferation and survival, including Raf, Akt or Cdk4 are clients of Hsp90 (Maloney and Workman, 2002) . We have shown that Hsp90 inhibition interferes with IKK activity at two levels, which can be discriminated by the time of exposure to GA. Long-time incubation severely diminished IKK expression levels, while already within a short time the induction of IKK kinase activity was affected. RC, an alternative specific inhibitor of Hsp90 ATPase activity, which is structurally unrelated to GA, had the same effect. GA-treatment for 14 h resulted in significant depletion of IKKa, IKKb and to some extent of IKKg, which is likely mediated by the 26S proteasome, as shown with a specific inhibitor. GA caused increased ubiquitination of IKKa, and of IKKb, which was blocked by CHX, implying that newly translated IKKa and IKKb require Hsp90 for stabilization. This was further supported by a pulse-chase analysis, which revealed that strongly reduced amounts of IKKa and IKKb were synthesized in the presence of GA during the labeling reaction. Under the conditions chosen, GA does not generally inhibit protein synthesis, as shown here for p65 and for other substrates in previous studies (Bijlmakers and Marsh, 2000; Fisher et al., 2000) . In contrast to the pronounced effect during synthesis, GA did not grossly affect the half-life of preformed IKKa and IKKb, which was in the range of several hours (Figure 7 and data not shown). This result was unexpected, since for Akt, RIP1 and several other protein kinases, an Hsp90 requirement was demonstrated for the stability of nascent molecules during the chase period (Lewis et al., 2000; Basso et al., 2002; Maloney and Workman, 2002) . Thus, over longer times the replenishment of the IKK subunits requires Hsp90 Smethionine (lane 1) and chased with complete medium without (lanes 2 and 3) or with GA (lanes 8 and 9, 'GA chase') for the indicated times. For lanes 4-6, cells were pretreated with GA for 2 h before labeling for 1 h with 35 S-methionine in the presence of GA ('GA pre'). Immunoprecipitated IKKa, IKKb or p65 as a control was analysed by SDS-PAGE and autoradiography. (b) COS7 cells were transfected with flagIKKa and flagIKKg. At 24 h after transfection, pulse-chase analysis was carried out as described above. Immunoprecipitation was performed with anti-flag antibody. Quantification was performed by TINA software. The intensity for t ¼ 0 h was set 100% and the values plotted on logarithmic scale Hsp90 requirement for IKK biogenesis and activation M Broemer et al function at the level of its synthesis. The requirement for Hsp90 activity is apparently restricted to a short time during synthesis, an observation, which has also been made for Lck, c-Src and Lyn (Bijlmakers and Marsh, 2000; Yorgin et al., 2000) . Given the structural resemblance and occurrence in a common complex, we speculate that both, IKKa and IKKb are under a similar control. How conformational maturation of the single IKKa, b and g chains is coordinated during synthesis and whether Hsp90 members and co-chaperones assist in the formation of a kinase holocomplex has to await future studies.
It is possible that Hsp90 affects IKKa or b stability exclusively by interfering with the biogenesis of both kinases. During translation Hsp90 may function as a chaperone, requiring its ATPase activity and incorrectly folded IKKa or b may be rapidly prone to degradation. In the mature IKK complex, precipitated via the IKKg component, Hsp90 remained bound in the presence of GA for at least 4 h (Figure 4) . Thus, GA does not rapidly affect the Hsp90-IKK association. Increasing loss of Hsp90 association at 14 h coincided with and may also be secondary to diminished levels of IKKa and IKKb.
The progressive loss of IKK subunits at 14 h of GA exposure is a significant contribution to the strongly impaired total IKK kinase and NF-kB activity induced by TNFa, IL-1b or PMA. Likewise, constitutive NF-kB and IKK activities in HRS cells were almost completely abrogated at this time of GA incubation. However, two initial observations indicate a second requirement of Hsp90 for the activation of IKK. Firstly, the loss of induced NF-kB and IKK kinase activity was more pronounced than the reduction of kinase expression levels and secondly, kinase activation dropped at earlier time points than the expression levels. The first significant drop occurred between 0.5 h (for IL-1b and constitutively activated IKK) and 4 h (for TNFa and PMA), the second strong decline at 14 h and was accompanied with pronounced reduction of kinase levels. In each of these early events, where expression levels were unaffected, GA strongly reduced, or even completely abolished kinase activation. GA also strongly inhibited kinase activity of co-transfected IKKb and IKKg, as shown by diminished IkBa phosphorylation and autophosphorylation, without markedly affecting protein levels. Thus, full enzymatic activity of the IKK complex, tested under diverse conditions, requires Hsp90 function. The inhibition of kinase activity of transfected IKKb makes it unlikely that instability or functional impairment of an unknown activating component accounts for the inhibitory effect of GA on IKK activity. This is noteworthy, since Hsp90 has been shown to act in the TNFa cascade at several steps. GA destabilizes RIP1, which by itself may account for loss of IKK activation (Lewis et al., 2000; Chen et al., 2002) and abrogates recruitment of the IKK complex to TNF receptor 1 (Chen et al., 2002) . However, RIP1 is not required for IL-1b or PMA induced NF-kB activation (Hsu et al., 1996; Kelliher et al., 1998) . Chen et al. (2002) did not observe degradation of IKK components in HeLa cells treated with GA for 15 h. It remains at present unclear whether cell type and growth conditions may affect the kinetic of GA-induced IKK depletion. In our hands loss of IKKs and of RIP1 was less and kinetically more delayed in HeLa cells compared to lymphoma cells.
It can only be speculated how Hsp90 (and cochaperones) may facilitate IKK activation, since little is known about the activation mechanism. It has been suggested that IKKg forms a tetrameric scaffold and can sequester two kinase dimers (Tegethoff et al., 2003) . This provides the possibility that IKK kinase activity is regulated by mutual trans-autophosphorylation of two kinase dimers upon allosteric structural alterations of the IKKg scaffold. These could be induced by the binding of activating polypeptides or by recruitment to membrane anchored complexes (Tegethoff et al., 2003) . Since IKK activation by diverse agents, acting through different mediators upstream of IKK, was blocked by GA, a requirement of Hsp90 could be to facilitate such allosteric transition or to maintain the IKK complex in a conformation, which is requisite to binding of activators. Or it could regulate susceptibility to post-translational modification of IKKs that positively or negatively modulate kinase activity or even the activity of an unknown enzyme that mediates such modifications in all pathways investigated. Alternatively, Hsp90 could play a role in subcellular localization and traffic of IKK complexes. Whatever the precise mechanism, our data provide evidence for a general role of Hsp90 in IKK signaling in addition to its biosynthesis and potential assembly function.
Interestingly, similar to IKK, heme-regulated eIF2a kinase has a dual requirement for Hsp90 in both its synthesis/maturation and maintenance in an activatable conformation prior to its Hsp90-dependent autophosphorylation and activation by heme-deficiency (Shao et al., 2001) .
At present, it is unknown by which signals IKK is constitutively activated in HRS cells. The very similar sensitivity of constitutive and inducible IKK activation to GA suggests that IKK is constitutively activated in HRS by the same principle mechanism as by the canonical activators. We have shown that inhibition of constitutive NF-kB activity by GA is achieved only in HRS cells with wild type, but not in those with defective IkBa expression. Similarly, inhibition of constitutive NF-kB activity by sodium arsenite, which reacts with a conserved cystein in the activation loops of IKKa and b (Kapahi et al., 2000) , was only achieved in HRS cells with functional IkBa (Mathas et al., 2003) . Thus, in HRS cells loss of functional IkBa alone results in constitutive NF-kB activation, irrespective of normal expression of other IkBs Krappmann et al., 1999) and independent of the IKK activation status. While functional impairment of both IkBa alleles is very rare in Hodgkin's lymphoma, constitutive IKK activation is believed to account for persistent NF-kB activity in most cases (Staudt, 2000) . GA has antitumor activity and GA analogs are under evaluation in early clinical trials (Maloney and Workman, 2002 ). Since constitutive IKK and NF-kB is observed in a number of malignancies (Rayet and Gelinas, 1999) , the block of NF-kB activation by GA may be a critical aspect of the antitumor activity of this class of drugs.
Materials and methods
Cell culture
HeLa, 293 and COS7 cells were grown in Dulbecco's Modified Eagle's Medium (DMEM) (PAA), supplemented with 10% fetal calf serum (FCS), 1 mM sodium pyruvate and 100 U/ml penicillin/streptomycin. Namalwa, and the HRS cell lines L428, L540, L1236, HDLM-2 and KM-H2 were maintained in RPMI1640 (PAA), supplemented with 10% FCS, 2 mM Lglutamine, 1 mM sodium pyruvate and 100 U/ml penicillin/ streptomycin. Cells were treated with the following agents: 0.5 mM GA (Alexis), 0.5 mg/ml RC (Sigma), 20 ng/ml TNFa (Biomol), 10 ng/ml IL-1b (Alexis), 100 ng/ml PMA, 50 mg/ml ALLN, 25 mg/ml cycloheximide, 25 mM MG-132 (all Calbiochem). 293 cells were transfected by calcium phosphate precipitation using standard protocols. COS7 cells were transfected with Lipofectamine 2000 (Invitrogen).
Electrophoretic mobility shift assay (EMSA) and kinase assays
Whole-cell extracts were prepared in lysis buffer containing 20 mM HEPES pH 7.9, 350 mM NaCl, 0.5 mM EDTA, 0.1 mM EGTA, 1 mM MgCl 2 , 10% glycerol, 1% Nonidet P-40, complete protease inhibitor cocktail (Roche), 10 mM NaF, 8 mM b-glycerophosphate, 1 mM DTT. Electrophoretic mobility shift assays were performed as described Mathas et al., 2002) . For kinase assays, whole-cell lysates were prepared in 50 mM HEPES pH 7.5, 150 mM NaCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1% Triton X-100, protease-and phosphatase inhibitors. Kinase assays for cellular IKKa or transfected IKKb were performed as described and kinase reactions were carried out with 1 mg GST-IkBa (1-53) and 3 mCi g-32 P-ATP for 20 min at 371C. Kinase assays for cellular JNK was performed analogously, with JNK1 antibody (BD Pharmingen) for immunoprecipitation and GST-c-Jun (1-79) as substrate.
Western blotting and co-immunoprecipitation
For co-precipitation of Hsp90, lysis and immunoprecipitation was performed in 50 mM Tris-HCl, pH 7.5, 1% Nonidet P-40, 2 mM EDTA, 100 mM NaCl, protease and phosphatase inhibitors (TNESV). Extracts were precleared for 1 h with protein A sepharose. Precipitation for IKKg (1 mg IKKg FL-419, Santa Cruz) was carried out for 5 h and precipitates were washed five times with lysis buffer. Sepharose beads were boiled in SDS-sample buffer and the supernatant loaded on SDS-gels.
For Western blotting, proteins were transferred to PVDFmembranes and probed with the following antibodies: IKKa (BD Pharmingen), IKKb (Biosource), IKKg FL-419 (Santa Cruz), RIP1 (BD Pharmingen), Hsp90 H-114 (Santa Cruz), p65 (Biomol), IkBa C-21 (Santa Cruz), HA Y-11 (Santa Cruz), ubiquitin (Babco), flag M2 (Sigma).
Detection of polyubiquitinated proteins
In total, 3 Â 10 7 Namalwa cells per lane were treated with 0.5 mM GA for 5.5 h or left untreated, followed by incubation with 50 mg/ml ALLN for 1 h (together with GA). When indicated, 25 mg/ml cycloheximide was added 30 min before the addition of ALLN. Extracts were prepared in lysis buffer containing 20 mM Tris pH 7.5, 150 mM NaCl, 0.5% NP-40, 10% glycerol and 30 mM N-ethylmaleimide. Immunoprecipitation for IKKa was performed o/n with 1.25 mg monoclonal antibody against human IKKa or IgG 2b as isotype control. For Western blotting, incubation with anti-ubiquitin antibody was performed o/n at 41C. For detection of polyubiquitinated flagIKKb, 10 cm plates of COS7 cells were transfected with 5 mg DNA (plus 5 mg vector) using Lipofectamine 2000 (Invitrogen). The assay was performed as described above, with flag M2 antibody for immunoprecipitation.
Metabolic labeling and immunoprecipitation
HeLa cells (one 6 cm dish per point) were preincubated with 0.5 mM GA for 2 h at 371C or left untreated. Cells were washed once in DMEM without methionine (ICN) (10% FCS, 2 mM glutamine), following incubation with 80 mCi/ml 35 S-methionine (Amersham) for 1 h at 371C (with or without GA). The medium was replaced by complete DMEM medium (with or without GA) and further incubated for 30 min. Following this, cells were lysed in RIPA buffer (t ¼ 0) or further incubated for the indicated time periods. Extracts were precleared with protein A sepharose for 1 h and immunoprecipitation for IKKa (2 mg antibody, BD Pharmingen), IKKb (Cell signaling) or p65 (Santa Cruz) was carried out overnight at 41C. Protein A sepharose beads were washed five times with cold RIPA buffer, beads boiled in SDS-sample buffer for 5 min and the supernatant was separated by SDS-PAGE and analysed by autoradiography.
